Bax抑制剂-1通过限制肌醇需求酶1α信号保护小鼠免于非酒精性脂肪性肝炎
本研究在小鼠中探讨Bax抑制剂-1(BI-1)对非酒精性脂肪性肝炎(NASH)的保护作用。BI-1敲除小鼠经衣霉素或高脂饮食诱导后出现IRE1α依赖的NLRP3炎症小体激活、肝细胞死亡和纤维化;用小分子STF-083010或4μ8c抑制IRE1α核糖核酸酶活性可改善糖耐量并逆转NASH。人类NASH肝活检显示BI-1下调与IRE1α核糖核酸酶信号上调平行。作者认为靶向IRE1α依赖的NLRP3炎症小体信号可能成为NASH的治疗策略。
要点
- BI-1敲除小鼠经衣霉素处理一周内出现IRE1α依赖的NLRP3炎症小体激活、肝细胞死亡和肝衰竭。
- 高脂饮食喂养的BI-1敲除小鼠表现为NASH和2型糖尿病,肝脏IRE1α、XBP1和CHOP表达增强。
- STF-083010或4μ8c抑制IRE1α核糖核酸酶活性可改善BI-1敲除小鼠糖耐量并逆转NASH。
核心结论
- 作者认为,通过药物或BI-1靶向IRE1α依赖的NLRP3炎症小体信号可能成为NASH的实际治疗策略。
研究设计与样本
- 研究在野生型和BI-1敲除小鼠中急性用衣霉素(1 mg/kg)注射或慢性用高脂饮食喂养诱导内质网应激以确定NAFLD表型。
- 分析了人类NAFLD肝活检组织中BI-1与IRE1α核糖核酸酶信号的关系。
- 在高脂饮食诱导的NAFLD中评估了小分子STF-083010或4μ8c对IRE1α核糖核酸酶活性的药理抑制。
- 用IRE1α轴敲低或STF-083010/4μ8c抑制在原代小鼠肝细胞中确认了IRE1α核糖核酸酶活性介导NLRP3炎症小体激活和细胞死亡的肝细胞特异性作用。
主要发现
- 衣霉素处理的BI-1敲除小鼠肝脏显示IRE1α依赖的NLRP3炎症小体激活、肝细胞死亡、纤维化和脂质稳态失调,导致一周内肝衰竭。
- 人类NAFLD肝活检显示BI-1下调与IRE1α核糖核酸酶信号上调平行。
- 高脂饮食喂养的BI-1敲除小鼠出现NASH和2型糖尿病,肝脏IRE1α、XBP1和CHOP表达增强与NLRP3炎症小体和caspase-1/-11激活相关。
- IL-1β、IL-6、MCP1、CXCL1和ALT/AST水平升高分别显示显著炎症和损伤。
- 在BI-1敲除小鼠中,STF-083010或4μ8c有效拮抗IRE1α核糖核酸酶活性,改善糖耐量并从NASH中挽救。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Endoplasmic reticulum (ER) stress is activated in nonalcoholic fatty liver disease (NAFLD), raising the possibility that ER stress-dependent metabolic dysfunction, inflammation, and cell death underlie the transition from steatosis to steatohepatitis (nonalcoholic steatohepatitis; NASH). B-cell lymphoma 2 (BCL2)-associated X protein (Bax) inhibitor-1 (BI-1), a negative regulator of the ER stress sensor, inositol-requiring enzyme 1 alpha (IRE1α), has yet to be explored in NAFLD as a hepatoprotective agent. We hypothesized that the genetic ablation of BI-1 would render the liver vulnerable to NASH because of unrestrained IRE1α signaling. ER stress was induced in wild-type and BI-1-/- mice acutely by tunicamycin (TM) injection (1 mg/kg) or chronically by high-fat diet (HFD) feeding to determine NAFLD phenotype. Livers of TM-treated BI-1-/- mice showed IRE1α-dependent NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome activation, hepatocyte death, fibrosis, and dysregulated lipid homeostasis that led to liver failure within a week. The analysis of human NAFLD liver biopsies revealed BI-1 down-regulation parallel to the up-regulation of IRE1α endoribonuclease (RNase) signaling. In HFD-fed BI-1-/- mice that presented NASH and type 2 diabetes, exaggerated hepatic IRE1α, X-box binding protein 1 (XBP1), and C/EBP homologous protein (CHOP) expression was linked to activated NLRP3 inflammasome and caspase-1/-11. Rises in interleukin (IL)-1β, IL-6, monocyte chemoattractant protein 1 (MCP1), chemokine (C-X-C motif) ligand 1 (CXCL1), and alanine transaminase (ALT)/aspartate transaminase (AST) levels revealed significant inflammation and injury, respectively. Pharmacological inhibition of IRE1α RNase activity with the small molecules, STF-083010 or 4μ8c, was evaluated in HFD-induced NAFLD. In BI-1-/- mice, either treatment effectively counteracted IRE1α RNase activity, improving glucose tolerance and rescuing from NASH. The hepatocyte-specific role of IRE1α RNase activity in mediating NLRP3 inflammasome activation and cell death was confirmed in primary mouse hepatocytes by IRE1α axis knockdown or its inhibition with STF-083010 or 4μ8c. CONCLUSION: Targeting IRE1α-dependent NLRP3 inflammasome signaling with pharmacological agents or by BI-1 may represent a tangible therapeutic strategy for NASH. (Hepatology 2018).
引用
- Lebeaupin C, Vallée D, Rousseau D, et al. Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in mice. Hepatology. 2018. PMID: 29457838. doi:10.1002/hep.29847
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。